Literature DB >> 10818679

Animal models of melanoma: recent advances and future prospects.

N Bardeesy1, K K Wong, R A DePinho, L Chin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818679     DOI: 10.1016/s0065-230x(00)79004-x

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


× No keyword cloud information.
  11 in total

Review 1.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

Review 2.  Animal models of skin disease for drug discovery.

Authors:  Pinar Avci; Magesh Sadasivam; Asheesh Gupta; Wanessa Cma De Melo; Ying-Ying Huang; Rui Yin; Rakkiyappan Chandran; Raj Kumar; Ayodeji Otufowora; Theodore Nyame; Michael R Hamblin
Journal:  Expert Opin Drug Discov       Date:  2013-01-08       Impact factor: 6.098

3.  Invasive melanoma in Cdk4-targeted mice.

Authors:  R Sotillo; J F García; S Ortega; J Martin; P Dubus; M Barbacid; M Malumbres
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

Review 4.  G-protein-coupled receptors and melanoma.

Authors:  Hwa Jin Lee; Brian Wall; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2008-05-27       Impact factor: 4.693

Review 5.  Current State of Animal (Mouse) Modeling in Melanoma Research.

Authors:  Omer F Kuzu; Felix D Nguyen; Mohammad A Noory; Arati Sharma
Journal:  Cancer Growth Metastasis       Date:  2015-10-06

Review 6.  Animal models of melanoma: a somatic cell gene delivery mouse model allows rapid evaluation of genes implicated in human melanoma.

Authors:  Andrea J McKinney; Sheri L Holmen
Journal:  Chin J Cancer       Date:  2011-03

7.  Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo.

Authors:  Ho-Chung Chen; Jairo Sierra; Lumeng Jenny Yu; Robert Cerchio; Brian A Wall; James Goydos; Suzie Chen
Journal:  Oncotarget       Date:  2017-12-23

8.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

9.  p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis.

Authors:  Rubeta N Matin; Anissa Chikh; Stephanie Law Pak Chong; David Mesher; Manuela Graf; Paolo Sanza'; Valentina Senatore; Maria Scatolini; Francesca Moretti; Irene M Leigh; Charlotte M Proby; Antonio Costanzo; Giovanna Chiorino; Rino Cerio; Catherine A Harwood; Daniele Bergamaschi
Journal:  J Exp Med       Date:  2013-02-18       Impact factor: 14.307

Review 10.  Modeling Melanoma In Vitro and In Vivo.

Authors:  Kimberley A Beaumont; Nethia Mohana-Kumaran; Nikolas K Haass
Journal:  Healthcare (Basel)       Date:  2013-12-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.